162 studies on Thymosin class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research provides critical insights into the in vitro metabolic pathways of synthetic doping peptides, which is essential for developing robust and sensitive anti-doping tests. The identification of liver S9 frac…
This research highlights a critical, often overlooked, factor in analytical accuracy for peptide quantification, particularly in sensitive areas like doping analysis and biopharmaceutical research. The findings unders…
This study provides a critical analytical tool for the precise quantification of TB-500 and its active metabolites, offering unprecedented insights into its pharmacokinetics and pharmacodynamics. Understanding which m…
This review underscores the significant promise of injectable therapeutic peptides as novel tools in regenerative medicine and sports performance. Their ability to accelerate healing, reduce inflammation, and promote …
Understanding the exact chemical structure of Thymosin Alpha-1 is an absolutely crucial first step for any scientific investigation into its potential biological roles or therapeutic applications. This foundational ch…
Establishing a standardized chemical identity through resources like PubChem is foundational for all subsequent research into TB-500. It prevents ambiguity and ensures that studies conducted globally on this peptide a…
The withdrawal of this study highlights the inherent challenges in conducting clinical trials, especially for complex conditions like metastatic colorectal cancer where new treatment strategies are desperately needed.…
A Phase 1/2 trial is recruiting to assess TB-500's safety, tolerability, and pharmacokinetics, alongside exploratory cardiovascular biomarkers, in stable ASCVD patients.
This research highlights a novel mechanism by which Thymosin α1 can potentially contribute to HIV eradication strategies by targeting latent viral reservoirs. By inducing the secretion of the IL-15/RA complex from den…
This study provides compelling evidence that a combination of IL-15 and Thymosin α1 can effectively target and reduce senescent hepatic CD8+ T cells, offering a novel therapeutic strategy for chronic liver diseases an…
This review underscores the transformative potential of therapeutic peptides to address unmet needs in orthopaedic medicine. By offering targeted biological interventions, peptides could significantly improve patient …